Brind.
  1. Stryker is listed as a key player in the Knee Replacement Surgery Market, alongside companies based in Switzerland, Germany, and India.

Stryker's market presence is being driven by Mako placements and organic growth within the neurotechnology segment.

4 reports, 2 independent Updated Aug 11
Gone quiet
Reports
4
Developments
3
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Stryker's market presence is being driven by Mako placements and organic growth within the neurotechnology segment.

Who's involved

What this event is mainly about
NeurotechnologyStryker Corporation

How it developed

Newest first. Tap a step to see who reported it.
  1. Stryker expanded its capabilities through the Mako acquisition, positioning both companies as medtech powerhouses in surgical robotics.Sub-event
  2. Growth in Stryker's market is linked to Mako placements and Neurotechnology's organic growth.1 source
  3. Stryker received FDA clearance for Mako 4; Ion platform started procedures in Korea.1 source

Keep exploring

Part of

Stryker is listed as a key player in the Knee Replacement Surgery Market, alongside companies based in Switzerland, Germany, and India. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • insidermonkey.com
  • ZacksStryker's Robotics and Global Gains Offset by Macro Concerns Stryker Corporation SYK posted robust second-quarter 2025 results, with broad-based momentum across its core businesses. Net sales grew 11
  • ZacksISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue? Intuitive Surgical’s ISRG Ion platform continued its steep growth trajectory in the second quarter of 2025, with procedures surging 5
  • Unknown outlet